Although some animal studies have suggested the therapeutic potential of FGF-19 and FGF-21 in the treatment of obesity, diabetes or metabolic syndrome [6], still little is known about their role in the metabolic disorders. This evidence concerns the gene FGF19 and metabolic disease.